Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma

[1]  Ming-Wei Yang,et al.  Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management , 2020, Frontiers in Genetics.

[2]  Madeline G. Andrews,et al.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma. , 2020, Cell stem cell.

[3]  F. Labrousse,et al.  Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma , 2019, Journal of Neuro-Oncology.

[4]  John F. Magnotti,et al.  Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors , 2019, Proceedings of the National Academy of Sciences.

[5]  Raymond Y Huang,et al.  DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. , 2019, Neuro-oncology.

[6]  David T. W. Jones,et al.  Mutational patterns and regulatory networks in epigenetic subgroups of meningioma , 2019, Acta Neuropathologica.

[7]  Efstathios D. Gennatas,et al.  Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival , 2019, Neuro-oncology advances.

[8]  Angela N. Viaene,et al.  Transcriptome signatures associated with meningioma progression , 2019, Acta Neuropathologica Communications.

[9]  D. Mandell,et al.  Letter to the Editor. Classic radiological appearance of a carotid web. , 2019, Journal of neurosurgery.

[10]  M. McDermott,et al.  Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes , 2019, American Journal of Neuroradiology.

[11]  J. Reiter,et al.  Misactivation of Hedgehog signaling causes inherited and sporadic cancers. , 2019, The Journal of clinical investigation.

[12]  K. Aldape,et al.  Advances in multidisciplinary therapy for meningiomas. , 2019, Neuro-oncology.

[13]  A. Levine,et al.  The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters. , 2019, Cancer cell.

[14]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.

[15]  M. McDermott,et al.  Surgical outcomes after reoperation for recurrent non-skull base meningiomas. , 2019, Journal of neurosurgery.

[16]  M. McDermott,et al.  Surgical outcomes after reoperation for recurrent skull base meningiomas. , 2019, Journal of neurosurgery.

[17]  Samantha A. Morris,et al.  Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation with Single-Cell Transcriptomics. , 2018, Cell stem cell.

[18]  Efstathios D. Gennatas,et al.  Preoperative and postoperative prediction of long-term meningioma outcomes , 2018, PloS one.

[19]  S. Spiegl-Kreinecker,et al.  TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma , 2018, Neuro-oncology.

[20]  Inder M Verma,et al.  Glioblastoma Model Using Human Cerebral Organoids , 2018, Cell reports.

[21]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[22]  Susan M. Chang,et al.  Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation , 2018, Cell reports.

[23]  Jie Qiao,et al.  A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex , 2018, Nature.

[24]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[25]  M. McDermott,et al.  Salvage therapy outcomes for atypical meningioma , 2018, Journal of Neuro-Oncology.

[26]  D. Rowitch,et al.  Systematic Three-Dimensional Coculture Rapidly Recapitulates Interactions between Human Neurons and Astrocytes , 2017, Stem cell reports.

[27]  H. Wakimoto,et al.  Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas , 2017, Oncotarget.

[28]  Trevor J Pugh,et al.  Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas , 2017, Nature Communications.

[29]  M. Noda,et al.  Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells , 2017, Scientific Reports.

[30]  You-hong Cui,et al.  Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth , 2017, Nature Communications.

[31]  Martin Sill,et al.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. , 2017, The Lancet. Oncology.

[32]  R. Beroukhim,et al.  Genomic landscape of high-grade meningiomas , 2017, Journal of Neurological Surgery Part B: Skull Base.

[33]  Mark W. Youngblood,et al.  Integrated genomic analyses of de novo pathways underlying atypical meningiomas , 2017, Nature Communications.

[34]  David T. W. Jones,et al.  Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma , 2017, Acta Neuropathologica.

[35]  Thomas M. Norman,et al.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response , 2016, Cell.

[36]  Max A. Horlbeck,et al.  Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.

[37]  R. Beroukhim,et al.  Genomic landscape of intracranial meningiomas. , 2016, Journal of neurosurgery.

[38]  David B. Nyer,et al.  Regulation of cancer epigenomes with a histone-binding synthetic transcription factor , 2016, npj Genomic Medicine.

[39]  Mark W. Youngblood,et al.  Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas , 2016, Nature Genetics.

[40]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[41]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[42]  K. Aldape,et al.  TERT Promoter Mutations and Risk of Recurrence in Meningioma. , 2016, Journal of the National Cancer Institute.

[43]  Qiulian Wu,et al.  A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. , 2016, Cancer research.

[44]  Vicent Quilis-Quesada,et al.  The cochlea in skull base surgery: an anatomy study. , 2016, Journal of neurosurgery.

[45]  [World Health Organization classification of tumours of the central nervous system: a summary]. , 2016, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[46]  K. Mrozik,et al.  Therapeutic targeting of N‐cadherin is an effective treatment for multiple myeloma , 2015, British journal of haematology.

[47]  Alex A. Pollen,et al.  Molecular Identity of Human Outer Radial Glia during Cortical Development , 2015, Cell.

[48]  D. Rowitch,et al.  Dysregulation of astrocyte extracellular signaling in Costello syndrome , 2015, Science Translational Medicine.

[49]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[50]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[51]  P. Wen,et al.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review , 2014 .

[52]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[53]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[54]  K. Hansen,et al.  Functional normalization of 450k methylation array data improves replication in large cancer studies , 2014, Genome Biology.

[55]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[56]  David T. W. Jones,et al.  AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry , 2013, Acta Neuropathologica.

[57]  A. Stemmer-Rachamimov,et al.  Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation , 2013, Oncogene.

[58]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[59]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[60]  Murim Choi,et al.  Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO , 2013, Science.

[61]  Roland Eils,et al.  Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations , 2013, Acta Neuropathologica.

[62]  D. Jonker,et al.  Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors. , 2013, Current clinical pharmacology.

[63]  Robert T. Jones,et al.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations , 2013, Nature Genetics.

[64]  Milan Sonka,et al.  3D Slicer as an image computing platform for the Quantitative Imaging Network. , 2012, Magnetic resonance imaging.

[65]  Robert Krencik,et al.  Directed differentiation of functional astroglial subtypes from human pluripotent stem cells , 2011, Nature Protocols.

[66]  Loic Deleyrolle,et al.  The Cancer Stem Cell Hypothesis: Failures and Pitfalls , 2011, Neurosurgery.

[67]  J. Douglas Armstrong,et al.  Merged consensus clustering to assess and improve class discovery with microarray data , 2010, BMC Bioinformatics.

[68]  Juan F. García,et al.  Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. , 2010, Neuro-oncology.

[69]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[70]  Avi Ma'ayan,et al.  ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..

[71]  R. Beroukhim,et al.  Medical therapies for meningiomas , 2010, Journal of Neuro-Oncology.

[72]  M. Giovannini,et al.  Meningioma mouse models , 2010, Journal of Neuro-Oncology.

[73]  J. Honnorat,et al.  Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. , 2009, International journal of oncology.

[74]  A. Peterson,et al.  Retinoic Acid from the Meninges Regulates Cortical Neuron Generation , 2009, Cell.

[75]  D. Evans,et al.  Neurofibromatosis type 2 (NF2): A clinical and molecular review , 2009 .

[76]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[77]  Christopher R. Jacobs,et al.  Non-Canonical Wnt Signaling and N-Cadherin Related β-Catenin Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate , 2009, PloS one.

[78]  Hao Li,et al.  Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression , 2008, Nature Cell Biology.

[79]  M. Hollingsworth,et al.  ADH‐1 suppresses N‐cadherin‐dependent pancreatic cancer progression , 2008, International journal of cancer.

[80]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[81]  W. Paulus,et al.  Establishment of a benign meningioma cell line by hTERT-mediated immortalization , 2005, Laboratory Investigation.

[82]  Hans Clevers,et al.  FoxM1 is required for execution of the mitotic programme and chromosome stability , 2005, Nature Cell Biology.

[83]  A. Órfão,et al.  Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? , 2004, The Journal of molecular diagnostics : JMD.

[84]  S. Coons,et al.  Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. , 2004, Neuro-oncology.

[85]  K. Hoang-Xuan,et al.  Treatment of Meningeal Gliomatosis , 1999, Journal of Neuro-Oncology.

[86]  A. Yamaura,et al.  Topographical analysis of proliferating cells in meningiomas. Regional heterogeneity of the ability of tumors to proliferate. , 1999, Neurological Research.

[87]  H. Clevers,et al.  Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident , 1998, Current Biology.

[88]  L. Lim,et al.  Hepatocyte Nuclear Factor 3 / fork head Homolog 11 Is Expressed in Proliferating Epithelial and Mesenchymal Cells of Embryonic and Adult Tissues , 1996 .

[89]  M. Scholz,et al.  Intratumorous heterogeneity of chromosome 10 and 17 in meningiomas using non-radioactive in situ hybridization. , 1996, Journal of Neurosurgical Sciences.

[90]  R. O'rahilly,et al.  The Meninges in Human Development , 1986, Journal of neuropathology and experimental neurology.

[91]  J. Sneep,et al.  With a summary , 1945 .